Status:
COMPLETED
Impact of Very Low Nicotine Content Cigarettes in a Complex Marketplace
Lead Sponsor:
University of Minnesota
Collaborating Sponsors:
Duke University
University of California, San Francisco
Conditions:
Tobacco Smoking
Nicotine Dependence
Eligibility:
All Genders
21+ years
Phase:
PHASE3
Brief Summary
This project will examine the impact of very low nicotine content (VLNC) cigarettes in a complex tobacco and nicotine product marketplace. We will compare the number of cigarettes smoked and cigarette...
Detailed Description
This randomized, open label, controlled, multi-site study will simulate a "real world" tobacco environment by providing participants access to an experimental marketplace where they will be given vouc...
Eligibility Criteria
Inclusion
- Male or female;
- 18/21 (legal age to purchase tobacco at site);
- Biochemically confirmed smoker.
Exclusion
- Unstable health condition;
- Unstable medications;
- Pregnant or nursing.
Key Trial Info
Start Date :
June 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 10 2023
Estimated Enrollment :
799 Patients enrolled
Trial Details
Trial ID
NCT03272685
Start Date
June 1 2018
End Date
January 10 2023
Last Update
August 20 2024
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Tobacco Research Center
San Francisco, California, United States, 94110
2
Tobacco Research Programs
Minneapolis, Minnesota, United States, 55414
3
The Center for Addiction Science and Technology
Durham, North Carolina, United States, 27705
4
Wake Forest Tobacco Control Center of Excellence
Winston-Salem, North Carolina, United States, 27175